VIPoma diagnostic study of choice: Difference between revisions
Homa Najafi (talk | contribs) |
m (Bot: Removing from Primary care) |
||
| (One intermediate revision by one other user not shown) | |||
| Line 8: | Line 8: | ||
=== Study of choice === | === Study of choice === | ||
The [[diagnostic study of choice]] for Vipoma is the [[measurement]] of [[serum]] [[Vasoactive intestinal peptide|vasoactive intestinal polypeptide]] ([[Vasoactive intestinal peptide|VIP]]) [[concentration]]. | The [[diagnostic study of choice]] for Vipoma is the [[measurement]] of [[serum]] [[Vasoactive intestinal peptide|vasoactive intestinal polypeptide]] ([[Vasoactive intestinal peptide|VIP]]) [[concentration]].<ref>{{Cite journal | ||
| author = [[Sartaj Sandhu]] & [[Ishwarlal Jialal]] | |||
'''Note:''' Since [[serum]] [[VIP]] level may be normal between episodes of [[watery diarrhea]], measurement of [[serum]] [[VIP]] level should be repeated for [[diagnosis]] confirmation. | | title = ViPoma | ||
| year = 2019 | |||
| month = January | |||
| pmid = 29939520 | |||
}}</ref> | |||
'''Note:''' Since [[serum]] [[VIP]] level may be normal between episodes of [[watery diarrhea]], measurement of [[serum]] [[VIP]] level should be repeated for [[diagnosis]] confirmation. | |||
==References== | ==References== | ||
| Line 20: | Line 25: | ||
[[Category:Oncology]] | [[Category:Oncology]] | ||
[[Category:Up-To-Date]] | [[Category:Up-To-Date]] | ||
[[Category:Endocrinology]] | [[Category:Endocrinology]] | ||
[[Category:Gastroenterology]] | [[Category:Gastroenterology]] | ||
Latest revision as of 00:39, 30 July 2020
|
VIPoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
VIPoma diagnostic study of choice On the Web |
|
American Roentgen Ray Society Images of VIPoma diagnostic study of choice |
|
Risk calculators and risk factors for VIPoma diagnostic study of choice |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Homa Najafi, M.D.[2]
Overview
The diagnostic study of choice for Vipoma is the measurement of serum vasoactive intestinal polypeptide (VIP) concentration.
Diagnostic Study of Choice
Study of choice
The diagnostic study of choice for Vipoma is the measurement of serum vasoactive intestinal polypeptide (VIP) concentration.[1] Note: Since serum VIP level may be normal between episodes of watery diarrhea, measurement of serum VIP level should be repeated for diagnosis confirmation.
References
- ↑ Sartaj Sandhu & Ishwarlal Jialal (2019). "ViPoma". PMID 29939520. Unknown parameter
|month=ignored (help)